help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2003-0109
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abel, E. D.
Right arrow Articles by Wondisford, F. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abel, E. D.
Right arrow Articles by Wondisford, F. E.
Molecular Endocrinology 17 (9): 1767-1776
Copyright © 2003 by The Endocrine Society

Dominant Inhibition of Thyroid Hormone Action Selectively in the Pituitary of Thyroid Hormone Receptor-ß Null Mice Abolishes the Regulation of Thyrotropin by Thyroid Hormone

E. Dale Abel, Egberto G. Moura, Rexford S. Ahima, Angel Campos-Barros, Carmen C. Pazos-Moura, Mary-Ellen Boers, Helen C. Kaulbach, Douglas Forrest and Fredric E. Wondisford

Division of Endocrinology (E.D.A.), Metabolism and Diabetes and Program in Human Molecular Biology and Genetics, University of Utah, Salt Lake City, Utah 84112; Departamento de Ciencias Fisiologicas (E.G.M.), Instituto de Biologia, Universidade do Estado do Rio de Janeiro, 20550-030 Rio de Janeiro, Brazil; Division of Endocrinology (R.S.A.), Diabetes and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104; Department of Human Genetics (A.C.-B., D.F.), Mount Sinai School of Medicine, New York, New York 10029; Laboratorio de Endocrinologia Molecular (C.C.P.-M.), Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, 21000-000 Rio de Janeiro, Brazil; Division of Endocrinology and Metabolism (M.-E.B., H.C.K.), Beth Israel Deaconess Medical Center, Boston Massachusetts 02215; and Section of Endocrinology and Metabolism (F.E.W.), Pritzker School of Medicine, The University of Chicago, Chicago, Illinois 60637

Address all correspondence to: E. Dale Abel, Division of Endocrinology, Metabolism and Diabetes and Program in Human Molecular Biology and Genetics, University of Utah School of Medicine, 15 North 2030 East, Building 533, Room 3410B, Salt Lake City, Utah 84112. E-mail: dale.abel{at}hmbg.utah.edu. Address reprint requests to: Fredric E. Wondisford, Section of Endocrinology and Metabolism, Pritzker School of Medicine, The University of Chicago, 5841 South Maryland Avenue MC1027, Chicago, Illinois 60637.

Thyroid hormones, T4 and T3, regulate their own production by feedback inhibition of TSH and TRH synthesis in the pituitary and hypothalamus when T3 binds to thyroid hormone receptors (TRs) that interact with the promoters of the genes for the TSH subunit and TRH. All TR isoforms are believed to be involved in the regulation of this endocrine axis, as evidenced by the massive dysregulation of TSH production in mice lacking all TR isoforms. However, the relative contributions of TR isoforms in the pituitary vs. the hypothalamus remain to be completely elucidated. Thus, to determine the relative contribution of pituitary expression of TR-{alpha} in the regulation of the hypothalamic-pituitary-thyroid axis, we selectively impaired TR-{alpha} function in TR-ß null mice (TR-ß-/-) by pituitary restricted expression of a dominant negative TR-ß transgene harboring a {Delta}337T mutation. These animals exhibited 10-fold and 32-fold increase in T4 and TSH concentrations, respectively. Moreover, the negative regulation of TSH by exogenous T3 was completely absent and a paradoxical increase in TSH concentrations and TSH-ß mRNA was observed. In contrast, prepro-TRH expression levels in T3-treated TR-ß-/- were similar to levels observed in the {Delta}337/TR-ß-/- mice, and ligand-independent activation of TSH in hypothyroid mice was equivalently impaired. Thus, isolated TR-ß deficiency in TRH paraventricular hypothalamic nucleus neurons and impaired function of all TRs in the pituitary recapitulate the baseline hormonal disturbances that characterize mice with complete absence of all TRs.

NURSA Molecule Pages Link:

Nuclear Receptors:   TRα  |  TRβ
Ligands:   Thyroid hormone



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. L. Privalsky, S. Lee, J. B. Hahm, B. M. Young, R. N. G. Fong, and I. H. Chan
The p160 Coactivator PAS-B Motif Stabilizes Nuclear Receptor Binding and Contributes to Isoform-specific Regulation by Thyroid Hormone Receptors
J. Biol. Chem., July 17, 2009; 284(29): 19554 - 19563.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
F. Flamant, K. Gauthier, and J. Samarut
Thyroid Hormones Signaling Is Getting More Complex: STORMs Are Coming
Mol. Endocrinol., February 1, 2007; 21(2): 321 - 333.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. A. Nikrodhanond, T. M. Ortiga-Carvalho, N. Shibusawa, K. Hashimoto, X. H. Liao, S. Refetoff, M. Yamada, M. Mori, and F. E. Wondisford
Dominant Role of Thyrotropin-releasing Hormone in the Hypothalamic-Pituitary-Thyroid Axis
J. Biol. Chem., February 24, 2006; 281(8): 5000 - 5007.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
P. J. O'Shea, J. H. D. Bassett, S. Sriskantharajah, H. Ying, S.-y. Cheng, and G. R. Williams
Contrasting Skeletal Phenotypes in Mice with an Identical Mutation Targeted to Thyroid Hormone Receptor {alpha}1 or {beta}
Mol. Endocrinol., December 1, 2005; 19(12): 3045 - 3059.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
W. Wan, B. Farboud, and M. L. Privalsky
Pituitary Resistance to Thyroid Hormone Syndrome Is Associated with T3 Receptor Mutants that Selectively Impair {beta}2 Isoform Function
Mol. Endocrinol., June 1, 2005; 19(6): 1529 - 1542.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. M. Dupre, H. Guissouma, F. Flamant, I. Seugnet, T. S. Scanlan, J. D. Baxter, J. Samarut, B. A. Demeneix, and N. Becker
Both Thyroid Hormone Receptor (TR){beta}1 and TR{beta}2 Isoforms Contribute to the Regulation of Hypothalamic Thyrotropin-Releasing Hormone
Endocrinology, May 1, 2004; 145(5): 2337 - 2345.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society